DOROTHY IGWE: Open Payments
NPI 1073038824 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 12 payments from 9 companies in 2025. Trend: 2023 $116 · 2024 $310 · 2025 $554
Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $158 |
| Biogen, Inc. | 1 | $98 |
| Vanda Pharmaceuticals Inc. | 1 | $86 |
| E.R. Squibb & Sons, L.L.C. | 1 | $83 |
| Otsuka America Pharmaceutical, Inc. | 1 | $46 |
| ABBVIE INC. | 1 | $28 |
| Gilead Sciences, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: Ozempic, ZURZUVAE, FANAPT, COBENFY, REXULTI, EPKINLY, CAPLYTA, JARDIANCE.
Industry payments across AZ — which companies pay providers there.
